Share on LinkedInShare on LinkedIn

ARTICLE · 20 JANUARY 2023

Regulatory Challenges To Cannabis Financing

Davis+Gilbert LLP
Davis+Gilbert LLP
Contributor
Davis+Gilbert LLP

Davis+Gilbert LLP

Legal mastery is critical but not enough. Even the best legal strategies must work in tandem with...

View firm profile
Explore more from Davis+Gilbert LLP

Despite increased legalization at the state level of medical and adult-use recreational marijuana, illegality of non-hemp, cannabis at the federal level as a Schedule 1 controlled substance...

United StatesCannabis & Hemp

Despite increased legalization at the state level of medical and adult-use recreational marijuana, illegality of non-hemp, cannabis at the federal level as a Schedule 1 controlled substance under the Controlled Substances Act (CSA) is an impediment for businesses in the cannabis industry (MRBs) to get access to banking and financing. Federal agencies have provided guidance, but processes are complex and entail a great deal of risk for a financial institution.

Below are some of the key aspects of federal guidance and a look toward proposed legislation to alleviate the state and federal legal tensions.

Existing Legislation and Regulatory Schemes

The Bank Secrecy Act (BSA), which was instituted to prevent money laundering and financial crimes, is the primary challenge for financial institutions to contend with when attempting to do business with MRBs.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from